Month: February 2019

The stock of NUTRAFUELS INC (OTCMKTS:NTFU) registered a decrease of 32% in short interest. NTFU’s total short interest was 8,500 shares in February as published by FINRA. Its down 32% from 12,500 shares, reported previously. With 78,600 shares average volume, it will take short sellers 0 days to cover their NTFU’s short positions.

The stock increased 11.44% or $0.0195 during the last trading session, reaching $0.19. About 375,178 shares traded or 816.95% up from the average. NutraFuels, Inc. (OTCMKTS:NTFU) has 0.00% since February 24, 2018 and is . It has by 0.00% the SP500.

NutraFuels, Inc. manufactures and distributes oral spray nutritional and dietary products to retail and wholesale outlets. The company has market cap of $20.20 million. The companyÂ’s products include sleep spray to support a healthy sleep cycle and improve the quality of restful sleep; energize spray to enhance energy, and restore vigor and vitality; and garcinia cambogia spray, an appetite and weight management spray. It currently has negative earnings. It also offers NRG-X extreme energy spray to enhance energy and stamina; headache and pain spray to relieve headaches and pain; and hair, skin, and nails spray to nourish and encourage hair, skin, and nail growth.

More news for NutraFuels, Inc. (OTCMKTS:NTFU) were recently published by: Marketwired.com, which released: “NutraFuels (NTFU) Files its Application to Up List to the OTCQB OTC Market – Marketwired” on January 29, 2018. Globenewswire.com‘s article titled: “Freedom Leaf Inc. Announces National Distribution Agreement Other OTC:FRLF – GlobeNewswire” and published on February 28, 2018 is yet another important article.

Receive News Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

The burgeoning field of complementary medicines, including weight-loss products, is now a billion-dollar industry. Every year, more people are spending disposable income on complementary and alternative medicines that may prove to have no benefit for our health.

Garcinia Cambogia is one such example. Marketed as a weight-loss pill, it has had an exponential rise in sales since it was featured on the Doctor Oz show.

Garcinia cambogia is the former scientific name of a native Southeast Asian plant, belonging to the family Clusiaceae, that bears a pumpkin-shaped fruit. The skin of the fruit contains the active ingredient, hydroxycitric acid (HCA). HCA inhibits an enzyme that produces fatty acid, thus suppressing fatty acid and the processing of cholesterol.

But does this mode of action translate to the weight-loss claims associated with it? Or is it just clever marketing convincing us this product helps us lose weight?

Double-blinded, randomised controlled trials are the gold standard of clinical study and whenever possible should be conducted to test the effectiveness of a treatment compared to a placebo. Weight-loss products should be assessed for a minimum of six months, with a further six-month follow-up period (12 months total).

There has never been a long-term study investigating the efficacy of Garcinia Cambogia. Most of the studies have been conducted in animals.

In fact, the majority of well-designed trials investigating the effect of this product on weight loss have found no effect that is of clinical relevance. In a 12-week double-blind, placebo-controlled trial conducted in humans, people receiving 3000mg of Garcinia Cambogia extract (1500mg of the active component HCA) per day lost the same amount of weight as the control group.

Another 12-week study with a four-week follow-up (16 weeks total) also found no greater weight-loss effect than for a placebo control group. For those studies where a statistically significant effect was reported, the weight loss was around one kilogram more than for those receiving a placebo pill.

Positive and greater weight losses were found in some studies, but this effect is suppressed when looking at all of the studies combined.

With respect to other health benefits from taking this supplement, the evidence to suggest it can improve blood cholesterol levels is lacking.

Most importantly, the product safety profile of Garcinia Cambogia has been adequately tested and there appear to be no issues.

Some complementary medicines have been found to contribute to improved health outcomes, through increased efficacy and cost-effectiveness. However, if there is to be a role for such complementary and alternative weight-loss products and medicines, we must build upon the evidence to investigate whether these increasingly popular products are a viable treatment option.

A recent Obesity Australia and Price Waterhouse Coopers report found obesity cost Australia A$8.6 billion in 2011-2012, with the indirect costs far higher. We must establish whether complementary medicines have a role to play in preventing and treating obesity. If we take no action to reduce obesity rates, an additional 2.4 million people will become obese at a cost of $87.7 billion over 10 years.

Please visit this website if you’re interested in taking part in our clinical weight-loss trials on Garcinia Cambogia and other weight-loss supplements.

Mycio Wealth Partners Llc increased Disney Walt Co (DIS) stake by 35.84% reported in 2018Q3 SEC filing. Mycio Wealth Partners Llc acquired 4,493 shares as Disney Walt Co (DIS)’s stock rose 1.07%. The Mycio Wealth Partners Llc holds 17,031 shares with $1.99 million value, up from 12,538 last quarter. Disney Walt Co now has $171.81 billion valuation. The stock increased 0.84% or $0.96 during the last trading session, reaching $115.25. About 8.74 million shares traded or 6.78% up from the average. The Walt Disney Company (NYSE:DIS) has risen 6.27% since February 24, 2018 and is uptrending. It has outperformed by 6.27% the SP500. Some Historical DIS News: 31/05/2018 – Trump Wants Apology From Disney’s Iger Over 2017 Russia Report; 07/05/2018 – The Business Times: #Comcast prepares all-cash bid to gate-crash #Disney-Fox deal; 25/05/2018 – To @jimcramer, comparing Netflix and Disney is not particularly useful; 05/04/2018 – SAUDI CROWN PRINCE MET WITH WARNER BROS., DISNEY, MAGIC LEAP; 26/04/2018 – DISNEY SAYS NEW `AVENGERS’ OPENS WITH $39M INTERNATIONALLY; 08/05/2018 – ♫ Reuters Insider – Disney revenue up on ‘Black Panther’; 30/05/2018 – Trump wades into furor over racist Roseanne Barr tweet; 13/05/2018 – DISNEY: `AVENGERS: INFINITY WAR’ GLOBAL GBO $1.61B TO DATE; 19/04/2018 – Dolby and Disney Announce Extended Theatrical Collaboration; 29/03/2018 – ITALIA INDEPENDENT GROUP SPA IINT.Ml – HAS SIGNED LICENSE AGREEMENT TO MAKE DISNEY, MARVEL AND LUCAS FILM THEMED GLASSES

NUTRAFUELS INC (OTCMKTS:NTFU) had a decrease of 32% in short interest. NTFU’s SI was 8,500 shares in February as released by FINRA. Its down 32% from 12,500 shares previously. With 78,600 avg volume, 0 days are for NUTRAFUELS INC (OTCMKTS:NTFU)’s short sellers to cover NTFU’s short positions. The stock increased 11.44% or $0.0195 during the last trading session, reaching $0.19. About 375,178 shares traded or 816.95% up from the average. NutraFuels, Inc. (OTCMKTS:NTFU) has 0.00% since February 24, 2018 and is . It has by 0.00% the SP500.

More news for NutraFuels, Inc. (OTCMKTS:NTFU) were recently published by: Globenewswire.com, which released: “Freedom Leaf Inc. Announces National Distribution Agreement Other OTC:FRLF – GlobeNewswire” on February 28, 2018. Marketwired.com‘s article titled: “NutraFuels (NTFU) Files its Application to Up List to the OTCQB OTC Market – Marketwired” and published on January 29, 2018 is yet another important article.

NutraFuels, Inc. manufactures and distributes oral spray nutritional and dietary products to retail and wholesale outlets. The company has market cap of $20.20 million. The companyÂ’s products include sleep spray to support a healthy sleep cycle and improve the quality of restful sleep; energize spray to enhance energy, and restore vigor and vitality; and garcinia cambogia spray, an appetite and weight management spray. It currently has negative earnings. It also offers NRG-X extreme energy spray to enhance energy and stamina; headache and pain spray to relieve headaches and pain; and hair, skin, and nails spray to nourish and encourage hair, skin, and nail growth.

Since September 4, 2018, it had 0 buys, and 16 selling transactions for $11.46 million activity. Shares for $5.73 million were sold by IGER ROBERT A. 29,192 shares valued at $3.44M were sold by Parker Mary Jayne on Wednesday, October 3. $124,178 worth of stock was sold by BRAVERMAN ALAN N on Friday, December 28. On Wednesday, February 6 the insider WOODFORD BRENT sold $227,200.

Among 6 analysts covering Walt Disney (NYSE:DIS), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Walt Disney had 6 analyst reports since October 15, 2018 according to SRatingsIntel. The stock of The Walt Disney Company (NYSE:DIS) has “Buy” rating given on Tuesday, February 19 by Macquarie Research. The stock has “Overweight” rating by Morgan Stanley on Monday, October 15. The firm earned “Market Perform” rating on Thursday, February 7 by BMO Capital Markets. Argus Research maintained the stock with “Buy” rating in Monday, November 12 report. The stock of The Walt Disney Company (NYSE:DIS) has “Buy” rating given on Tuesday, November 27 by Imperial Capital. The stock has “Overweight” rating by Barclays Capital on Friday, October 19.

Mycio Wealth Partners Llc decreased Alphabet Inc stake by 1,062 shares to 2,284 valued at $2.73 million in 2018Q3. It also reduced Apple Inc (NASDAQ:AAPL) stake by 6,122 shares and now owns 163,382 shares. Spdr Series Trust (SDY) was reduced too.

Investors sentiment increased to 1.27 in 2018 Q3. Its up 0.04, from 1.23 in 2018Q2. It improved, as 61 investors sold DIS shares while 549 reduced holdings. 149 funds opened positions while 628 raised stakes. 890.89 million shares or 8.78% less from 976.63 million shares in 2018Q2 were reported. Northrock invested in 3,160 shares. 4,090 are held by Freestone Company. Strategy Asset Managers Ltd Com owns 81,949 shares for 0% of their portfolio. Soros Fund Mngmt Ltd Llc invested in 0.77% or 299,000 shares. Old Second Bancorp Of Aurora invested 0.93% in The Walt Disney Company (NYSE:DIS). Van Eck Corp stated it has 0.23% in The Walt Disney Company (NYSE:DIS). Jarislowsky Fraser Ltd holds 0.01% of its portfolio in The Walt Disney Company (NYSE:DIS) for 9,135 shares. Highbridge Capital Mngmt Ltd Liability Com holds 37,195 shares. Dubuque State Bank Comm accumulated 40,047 shares. Mckinley Carter Wealth Incorporated invested in 0.53% or 15,346 shares. 1.82 million are held by Apg Asset Mngmt Nv. Addenda, Quebec – Canada-based fund reported 63,069 shares. Harvest invested in 5,738 shares. State Of Alaska Department Of Revenue stated it has 343,153 shares or 0.67% of all its holdings. Acadian Asset Mngmt Ltd Liability Corp, a Massachusetts-based fund reported 1.35 million shares.

More notable recent The Walt Disney Company (NYSE:DIS) news were published by: Seekingalpha.com which released: “YouTube ads pulled over exploitation fears – Seeking Alpha” on February 21, 2019, also Bizjournals.com with their article: “Disney (NYSE: DIS) shares new additions on way for Epcot theme park in Orlando – Orlando Business Journal – Orlando Business Journal” published on February 21, 2019, Seekingalpha.com published: “Disney: Forced To Transform Its Business – Seeking Alpha” on February 19, 2019. More interesting news about The Walt Disney Company (NYSE:DIS) were released by: Seekingalpha.com and their article: “Walt Disney Q1 2019 Earnings Preview – Seeking Alpha” published on February 04, 2019 as well as Seekingalpha.com‘s news article titled: “WarnerMedia talks late-2019 streaming plans – Seeking Alpha” with publication date: February 11, 2019.